John Throup

Biography

 John is responsible for leading the development of assets in our Immunoscience pipeline. John is accountable for developing and implementing the drug development strategy across all phases of development from Phase 1 through registration and life cycle management.   John joined Bristol-Myers Squibb in 2014 following 15 years at GlaxoSmithKline (GSK), where he most recently was Head of Operations and Strategy for the Immuno-inflammation and Infectious Diseases franchise.  Prior to that role, John led the development of selected early stage assets and partnered with biotech companies to bring early stage assets into GSK.    John received his BSc in Food Science and his Ph.D. in Molecular Microbiology, both from the University of Nottingham in his native UK.  John’s academic research focused on bacterial quorum sensing and host-pathogen interactions which led to a post-doctoral position exploring signaling as a potential antibacterial target.    In addition to his scientific expertise, John is an accomplished drug development leader.  He believes the most exciting part of his work is seeing molecules unveil themselves during the development process, turning from molecules to medicines that have the potential to help patients.  John enjoys knitting together diverse perspectives to create new and innovative strategies to bring forward medicines for patients who need them.  John hopes to be known by his colleagues as transparent, thoughtful, hard-working and most of all, objective.

Research Interest

 Immunology